View Author

Vermont, C.L.

( C.L. Vermont)


meningococcal patient disease meningococcal disease chemokine level meningococcal sepsis sepsis blood protein study polymorphism catheter culture strain infection children factor receptor chemokine levels shock severity blood cultures laboratory score value serum hospital genotype sch nicu neonate cytokine outcome disease severity control tumor necrosis factor clone susceptibility cons-positive blood cultures interleukin individual neisseria meningitidis parameter sample page number citation purposes microbiol necrosis vermont il -6 staphylococci netherland antibiotic 1 vermont admission correlation bacteremia table mortality pulsed-field gel electrophoresis 24 hours prism serum chemokine levels nonsurvivor coagulase-negative staphylococci population care vol 10 prism scores winkel jg nosocomial wch nicu difference risk factors macrophage group umbilical intravascular response il -8 influence




3 Most Recent Publications

CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity (Article)
Vermont, C.L. Hazelzet, J.A. Kleijn, E.D. de Dobbelsteen, G.J.P.M. van den Groot, R. de
2006-01-01
Bench-to-bedside review: genetic influences on meningococcal disease (Article)
Vermont, C.L. Hazelzet, J.A. Groot, R. de
2002-01-01
Persistence of clones of coagulase-negative staphylococci among premature neonates in neonatal intensive care units: two-center study of bacterial genotyping and patient risk factors (Article)
Vermont, C.L. Hartwig, N.G. Fleer, A. Man, P. de Groot, R. de Belkum, A.F. van Verbrugh, H.A. Anker, J.N. van den
1998-01-01